PMCTPharmaCountry
    Home

MNEXSPIKE DISPERSION INYECTABLE EN JERINGA PRECARGADA

MB
MODERNA BIOTECH SPAIN SL
Marketing Authorization Holder Β· Finished Dosage FormsFlag of ESSpain
Rx

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Injectables & Parenterals / Small Volume Parenterals (SVP)

Trade Type

Sell

Product Name

MNEXSPIKE DISPERSION INYECTABLE EN JERINGA PRECARGADA

Details

ARNM QUE CODIFICA EL DOMINIO N-TERMINAL Y EL DOMINIO DE UNION AL RECEPTOR DE LA GLICOPROTEINA DE LA ESPICULA DE SARS-COV 2 (XBB.1.5.) 0,05 mg/ml

Substance

ARNM QUE CODIFICA EL DOMINIO N-TERMINAL Y EL DOMINIO DE UNION AL RECEPTOR DE LA GLICOPROTEINA DE LA ESPICULA DE SARS-COV 2 (XBB.1.5.)

Registered Market

Specifications

  • Dosage Form: Injectable dispersion (pre-filled syringe)
  • ATC Code: J07BN01
  • Packaging: MNEXSPIKE DISPERSION injectable in pre-filled syringe, 1 pre-filled syringe of 0,2 ml β€’ MNEXSPIKE DISPERSION injectable in pre-filled syringe, 10 pre-filled syringes of 0,2 ml

Documents

Drug Marketing Authorization Number
Document No.: 1252010004
Issue Date: Apr 8, 2026
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More